Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane
- 22 September 1998
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 356 (2-3) , 109-119
- https://doi.org/10.1016/s0014-2999(98)00487-7
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implicationsLife Sciences, 1997
- Electrophysiological Effects of Olanzapine, a Novel Atypical Antipsychotic, on A9 and A10 Dopamine NeuronsNeuropsychopharmacology, 1996
- Comparison of second-messenger responses to muscarinic receptor stimulation in M1-transfected A9 L cellsCellular Signalling, 1995
- Molecular Cloning, Stable Expression and Desensitization of the Human Dopamine D1B / D5 ReceptorJournal of Receptor Research, 1993
- Stimulus-transcription coupling in neurons: role of cellular immediate-early genesTrends in Neurosciences, 1989
- Expression of c- fos Protein in Brain: Metabolic Mapping at the Cellular LevelScience, 1988
- Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine NeuronsScience, 1983
- Treatment of schizophreniaProgress in Neuro-Psychopharmacology, 1979
- Antipsychotic drug doses and neuroleptic/dopamine receptorsNature, 1976
- THE INHIBITION OF THE CONDITIONED RESPONSE AND THE COUNTERACTION OF SCHIZOPHRENIA BY MUSCARINIC STIMULATION OF THE BRAINAnnals of the New York Academy of Sciences, 1957